SREBF1 and nonpapillary renal cell carcinoma: Lee et al. found that SREBP1c overexpression promotes lipogenesis and tumor cell proliferation, and RNF20 inhibits lipogenesis and cell cycle progression in ccRCC by inhibiting the SREBP-1c pathway [49].